Search results
Showing 5536 to 5550 of 8314 results
Recommendation ID NG218/10 Question School-based versus GP-based catch-up campaigns: What is the effectiveness and acceptability of school-based
Recommendation ID NG216/04 Question Responding to an escalation of need: What is the effectiveness and acceptability of social work interventions
Recommendation ID NG96/5 Question Advance planning about end of life care:- What is the effectiveness and cost effectiveness of advance
Recommendation ID NG1/2 Question What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula-fed infants
Recommendation ID NG65/5 Question Biological therapies for peripheral spondyloarthritis:- What is the effectiveness and cost effectiveness
Recommendation ID NG96/1 Question Models of care and support at home:- What is the effectiveness and cost effectiveness of care and support
Recommendation ID NG18/01 Question Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness
Recommendation ID NG108/2 Question Targeted interventions to support and improve decision-making capacity for treatment:- What is the effectiveness
Recommendation ID NG108/1 Question Training and support for practitioners:- What is the effectiveness and cost effectiveness of different
Recommendation ID NG96/2 Question Identifying health conditions:- What is the effectiveness and cost effectiveness of different ways of
Recommendation ID PH54/4 Question What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with
Recommendation ID NG65/4 Question Pharmacological management of peripheral spondyloarthritis:- What is the comparative effectiveness and
Recommendation ID NG115/8 Question Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of different
Recommendation ID NG115/9 Question Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of seasonal
Recommendation ID NG196/6 Question Rate-control drug treatment for people aged 75 and over with atrial fibrillation: What is the comparative